egSEQ Comprehensive Solid Tumours Panel is a hybridisation-based targeted sequencing panel covering 641 genes, 15 MSI sites and 38 fusion sites related to solid tumours and targeted therapies, allowing accurate, comprehensive and cost-effective analysis of all types of mutations, including SNVs, InDels, CNVs, and rearrangements. egSEQ Comprehensive Solid Tumours Panel provides a comprehensive approach to analysing actionable biomarkers relevant to oncological diagnosis, prognosis, and therapy.

Features

• 2.13Mb target region coverage, including 641 genes and 38 gene fusion intron regions.

• TMB and MSI for immunotherapy evaluation.

• Market-leading capture efficiency of up to 75% and exceptional uniformity with 20X > 99%.

• Available with UMI adapter for more precise analysis.

Applications

• Targeted therapy and concomitant diagnosis.

• Mutation analysis of tumour-related genes.

• Suitable for patients with existing solid tumours and those with a family history.